Asthma-Related Outcomes in A Real-World Study of MP-AzeFlu to Treat Allergic Rhinitis

Ludger Klimek; Petr Cap; Gabriella Galffy; Melanie Emmeluth; Arkady Koltun; Ferdinand Kopietz; Duc Tung Nguyen; Hans Christian Kuhl; Ranny Van Weissenbruch; Wolfgang Pohl; David Price; Glennis Scadding; Joaquim Mullol

doi:10.1016/j.jaci.2019.12.802

Asthma-Related Outcomes in A Real-World Study of MP-AzeFlu to Treat Allergic Rhinitis

Ludger Klimek, Petr Cap, Gabriella Galffy, Melanie Emmeluth, Arkady Koltun, Ferdinand Kopietz, Duc Tung Nguyen, Hans Christian Kuhl, Ranny Van Weissenbruch, Wolfgang Pohl, David Price, Glennis Scadding, Joaquim Mullol

Research output: Contribution to journal › Article › peer-review

Abstract

Rationale
Up to 40% of allergic rhinitis (AR) patients have comorbid asthma with need for treatment. Poor control of AR predicts poor control of asthma and may necessitate increased use of rescue treatment. We evaluated the effect of MP-AzeFlu on asthma symptoms and reliever medication use in patients with comorbid AR and asthma.

Original language	English
Pages (from-to)	AB24-AB24
Number of pages	1
Journal	Journal of Allergy and Clinical Immunology
Volume	145
Issue number	2, Supplement
Early online date	24 Feb 2020
DOIs	https://doi.org/10.1016/j.jaci.2019.12.802
Publication status	Published - Feb 2020
Event	2020 AAAAI Annual Meeting - Philadelphia, United States Duration: 13 Mar 2020 → 16 Mar 2020

Access to Document

10.1016/j.jaci.2019.12.802Licence: Unspecified

http://www.sciencedirect.com/science/article/pii/S0091674919325047

Cite this

Klimek, L., Cap, P., Galffy, G., Emmeluth, M., Koltun, A., Kopietz, F., Nguyen, D. T., Kuhl, H. C., Van Weissenbruch, R., Pohl, W., Price, D., Scadding, G., & Mullol, J. (2020). Asthma-Related Outcomes in A Real-World Study of MP-AzeFlu to Treat Allergic Rhinitis. Journal of Allergy and Clinical Immunology, 145(2, Supplement), AB24-AB24. https://doi.org/10.1016/j.jaci.2019.12.802

Klimek, L, Cap, P, Galffy, G, Emmeluth, M, Koltun, A, Kopietz, F, Nguyen, DT, Kuhl, HC, Van Weissenbruch, R, Pohl, W, Price, D, Scadding, G & Mullol, J 2020, 'Asthma-Related Outcomes in A Real-World Study of MP-AzeFlu to Treat Allergic Rhinitis', Journal of Allergy and Clinical Immunology, vol. 145, no. 2, Supplement, pp. AB24-AB24. https://doi.org/10.1016/j.jaci.2019.12.802

@article{447ddb5df9b24bc294dcf47b7eff768c,

title = "Asthma-Related Outcomes in A Real-World Study of MP-AzeFlu to Treat Allergic Rhinitis",

abstract = "RationaleUp to 40% of allergic rhinitis (AR) patients have comorbid asthma with need for treatment. Poor control of AR predicts poor control of asthma and may necessitate increased use of rescue treatment. We evaluated the effect of MP-AzeFlu on asthma symptoms and reliever medication use in patients with comorbid AR and asthma.",

author = "Ludger Klimek and Petr Cap and Gabriella Galffy and Melanie Emmeluth and Arkady Koltun and Ferdinand Kopietz and Nguyen, {Duc Tung} and Kuhl, {Hans Christian} and {Van Weissenbruch}, Ranny and Wolfgang Pohl and David Price and Glennis Scadding and Joaquim Mullol",

year = "2020",

month = feb,

doi = "10.1016/j.jaci.2019.12.802",

language = "English",

volume = "145",

pages = "AB24--AB24",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Mosby/Elsevier,",

number = "2, Supplement",

note = "2020 AAAAI Annual Meeting ; Conference date: 13-03-2020 Through 16-03-2020",

}

TY - JOUR

T1 - Asthma-Related Outcomes in A Real-World Study of MP-AzeFlu to Treat Allergic Rhinitis

AU - Klimek, Ludger

AU - Cap, Petr

AU - Galffy, Gabriella

AU - Emmeluth, Melanie

AU - Koltun, Arkady

AU - Kopietz, Ferdinand

AU - Nguyen, Duc Tung

AU - Kuhl, Hans Christian

AU - Van Weissenbruch, Ranny

AU - Pohl, Wolfgang

AU - Price, David

AU - Scadding, Glennis

AU - Mullol, Joaquim

PY - 2020/2

Y1 - 2020/2

N2 - RationaleUp to 40% of allergic rhinitis (AR) patients have comorbid asthma with need for treatment. Poor control of AR predicts poor control of asthma and may necessitate increased use of rescue treatment. We evaluated the effect of MP-AzeFlu on asthma symptoms and reliever medication use in patients with comorbid AR and asthma.

AB - RationaleUp to 40% of allergic rhinitis (AR) patients have comorbid asthma with need for treatment. Poor control of AR predicts poor control of asthma and may necessitate increased use of rescue treatment. We evaluated the effect of MP-AzeFlu on asthma symptoms and reliever medication use in patients with comorbid AR and asthma.

U2 - 10.1016/j.jaci.2019.12.802

DO - 10.1016/j.jaci.2019.12.802

M3 - Article

SN - 0091-6749

VL - 145

SP - AB24-AB24

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 2, Supplement

T2 - 2020 AAAAI Annual Meeting

Y2 - 13 March 2020 through 16 March 2020

ER -

Asthma-Related Outcomes in A Real-World Study of MP-AzeFlu to Treat Allergic Rhinitis

Abstract

Access to Document

Fingerprint

Cite this